Why physicians join our nephrology community
Sermo’s nephrology physician network provides practicing nephrologists with a secure, peer-driven platform to discuss the latest in dialysis modalities, transplant medicine, glomerular diseases, and CKD management. Whether you’re managing an ESRD clinic, researching novel renal therapies, or diagnosing rare kidney disorders, Sermo connects you to peers facing similar challenges—from managing fluid and electrolyte imbalances to navigating the complexities of dual-organ transplants.
Earn money sharing your nephrology expertise
Learn why surveys are worth it for nephrologists and tackle topics such as:
- Surveys on the adoption of new therapies for IgA nephropathy
- Opinion polls on preferred dialysis modalities for new-start ESRD patients
- Research studies on managing anemia in chronic kidney disease

Access nephrology drug insights from peers
Get practical, peer-reviewed information on renal therapies:
- Detailed safety profiles of immunosuppressants and phosphate binders
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines for new therapies and practical use cases

Learn from nephrology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Discussing dialysis options with patients and families
- Showing empathy when managing end-of-life care decisions
- Barriers to medication adherence in the CKD population
- Emerging treatments for rare genetic kidney diseases

Hear from fellow physician peers
I have been a member of Sermo for years. I am completely satisfied and participate in different areas, if I have time, I do surveys, and withdraw when I have accumulated a certain amount, I spend it to enjoy.
It’s a nice collegial environment with mostly sincere physicians from around the world.
I value the diversity of opinions on population and public health issues from a local practice perspective.
Frequently asked questions
Sermo’s nephrology community regularly shares updates and discussions around FDA/EMA approvals, trial outcomes, and real-world experiences with new therapies for CKD, GN, and ESRD complications.
Yes. Our drug ratings feature allows nephrologists to review and compare medications across efficacy, safety, and tolerability—based on real-world experiences.
Absolutely. Sermo members frequently share information related to clinical trial eligibility for conditions like diabetic kidney disease and lupus nephritis, as well as recruitment strategies.
Yes. Whether you work in a university hospital, a private practice, or a dialysis center, Sermo provides a space to share your expertise and learn from others.
You’ll find case studies ranging from unresolved AKI and acid-base disorders to managing post-transplant complications and interpreting kidney biopsy results.
Yes. Many discussions focus on reimbursement for dialysis, prior authorizations for new drugs, and the operational challenges of running a nephrology practice.
Sermo enables real-time collaboration. Post a case summary and receive input within hours—helping you make confident decisions when time and clarity matter most.
Sermo is designed to complement—not replace—professional societies and formal networks. It gives physicians a place for real-time peer discussion, specialty-specific insights, and opportunities to contribute to paid research, all within a physician-only community that fits easily into day-to-day practice.
If you’d like to see how Sermo compares with other physician networks, explore how we differ from Doximity or M3 Global.
Start your nephrology journey on Sermo
Become part of a dynamic nephrology physician network of over 16,000 members dedicated to advancing kidney care and improving patient outcomes through peer collaboration and expert insights.



